BioCorteX
biocortex.com
Actively hiring
Microbiome
Biotechnology
Drug Discovery
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$5M
1 round on record
Latest round
$5M
Venture round · Mar 2023 · 3 yr ago
Backers
3
Draper Associates, Hoxton Ventures
The money's age
Long since its last round
42 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 27, 2023
Raised a round Venture round $5M · led by Sofinnova Partners · FinanzNachrichten.de
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2023 | $5M | Sofinnova Partners lead, Hoxton Ventures lead | FinanzNachrichten.de |
Backed byfrom the funds' portfolios and accelerator catalogs
Draper Associates 
Hoxton Ventures 
Sofinnova Partners Similar startupsby what they do, their industry and backers
AI-powered in silico toxicology platform for drug discovery. Predict mutagenicity, hERG, DILI, ADME and 55+ models from SMILES…
Metagen Therapeutics is a Japanese biotech startup founded by researchers from Juntendo University, Keio University and Tokyo Institute of…
PIRAMIDAL. Bridge in-vivo with in-silico intelligence.
Kanvas Biosciences has developed cutting-edge imaging technology to map the microbiome and develop therapeutics.
Outpost builds AI models of the human microbiome so drug, food, and ingredient R&D teams can predict microbiome interactions and flag risks…
AMILI runs Southeast Asia's first gut microbiome bank and offers microbiome testing and therapeutic research. Its data addresses the…
Overview
BioCorteX runs in-silico bridge trials that map how the microbiome changes a drug.
News
BioCorteX Announces Strategic Partnership with CD Biopharma of China
LONDON, November 24, 2025--BioCorteX, the UK-based pioneering tech bio company, said Wednesday that it had entered into a strategic collaboration with Chinese biotech company CD Biopharma to accelerate the development of next-generation precision immunoth
Read more
Report
BioCorteX Unveils Critical Bacteria Interactions in ADC Cancer Treatment, Enabled by Google Cloud
Read more
Report
BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures To Unlock Drug-Bacteria Interactions
BioCorteX, a digital medicine company that employs the Carbon Mirror platform, a first-principle computer simulation to understand drug-bacteria interactions and improve a person
Read more
Report
BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures To Unlock Drug-Bacteria Interactions
The company is developing precision medicine solutions using in silico simulation to solve the complex relationship bacteria, viruses and fungi play in health, disease and drug responseEdward Kliphuis
Read more
Report
Financials
Total raised
$5M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2023 | $5M | Details |